BeOne Medicines (ONC) Intangibles (2017 - 2026)

BeOne Medicines (ONC) has reported Intangibles for 10 consecutive years, with $61.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Intangibles rose 23.02% year-over-year to $61.7 million; the TTM figure through Mar 2026 stood at $61.7 million (up 23.02% YoY), while the FY2025 annual figure was $62.7 million, up 22.72% from the prior year.
• Intangibles retreated to $61.7 million in Q1 2026 per ONC's latest filing, from $62.7 million in the prior quarter.
• Across five years, Intangibles topped out at $64.9 million in Q2 2025 and bottomed at $39.7 million in Q1 2023.
• Historically, Intangibles has averaged $52.1 million across 5 years, with a median of $53.7 million in 2023.
• Annual changes were most pronounced in 2022 — Intangibles surged 851.73% — and 2023, when it fell 13.26%.
• BeOne Medicines' Intangibles stood at $40.6 million in 2022, then soared by 40.68% to $57.1 million in 2023, then decreased by 10.58% to $51.1 million in 2024, then advanced by 22.72% to $62.7 million in 2025, then decreased by 1.63% to $61.7 million in 2026.
• Business Quant data shows ONC's Intangibles at $61.7 million in Q1 2026, $62.7 million in Q4 2025, and $63.6 million in Q3 2025.